Fewer UC patients taking infliximab need surgery, study says

05/6/2013 | Healio

Treating severe ulcerative colitis with infliximab may reduce the likelihood patients will need a colon resection, researchers reported at a surgical conference. About 20% of UC patients generally need surgery, but researchers said the number was significantly reduced among those taking infliximab. Some 4.1% to 11.1% of treated patients underwent surgery, compared with 46.6% to 55.7% of untreated patients.

View Full Article in:

Healio

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
PacificSource
Boise, ID